A new CDx listing
https://themarketherald.com.au/gold-healthcare-real-estate-a-look-at-upcoming-ipos-2023-07-07/amp/
Cleo Diagnostics (ASX:COV) – healthcare: August 11Cleo Diagnostics (COV) is seeking to raise $12 million at 20 cents per share, listing on August 11.
The company specialises in providing solutions for the detection of ovarian cancer. That being said, the company states on its website: “The technology is not yet commercially available and remains subject to further testing.”
Regulatory approvals will also need to be won, a process that can take years.
Cleo will run blood tests through its own ‘CLEO Test-Kit,’ designed to detect a naturally occurring molecule in the body that only occurs when ovarian cancer is present.
Ann: Companion Diagnostic Study Initiated with UON, page-121
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
-0.095(5.44%) |
Mkt cap ! $281.0M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.78 | $1.62 | $285.9K | 170.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16759 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.69 | 12047 | 1 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |